New Antiviral, Antibacterial and Antifungal Agents

Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.

  • Mechanisms of action, preclinical data & pharmacology
  • Pharmacokinetics/pharmacodynamics
  • Clinical trials
  • Pharmacoepidemiology
  • New technologies in the development
  • Prescribing Improved agents
  • Advancement

Related Conference of New Antiviral, Antibacterial and Antifungal Agents

September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
November 06-07, 2017

3rd International Conference on Flu and Emerging Infectious Diseases

Las Vegas, Nevada, USA
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
31st August-1st September 2018

International Conference on Emerging Infectious Diseases

Zurich, Switzerland

New Antiviral, Antibacterial and Antifungal Agents Conference Speakers

Recommended Sessions

Related Journals

Are you interested in